Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Kidney Research and Clinical Practice
>
2016
>
35
Volume:
35
1. Corrigendum: RNA sequencing of the nephron transcriptome: a technical note Volume 34, Issue 4, December 2015, Pages 219-227.
Page:130—130
2. Is hypomagnesemia associated with using proton pump inhibitors?.
Page:128—129
3. Relapsing lupus enteritis in systemic lupus erythematosus.
Page:127—127
4. Successfully treated isolated renal artery pseudoaneurysm in a patient with Behçet's disease.
Page:123—126
5. Renal artery stenosis presenting with nephrotic-range proteinuria: a case report.
Page:119—122
6. Clinical significance of red blood cell distribution width in the prediction of mortality in patients on peritoneal dialysis.
Page:114—118
7. Comparison of uremic pruritus between patients undergoing hemodialysis and peritoneal dialysis.
Page:107—113
8. Predicting the probability of survival in acute paraquat poisoning.
Page:102—106
9. PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data.
Page:96—101
10. Risk factors and outcomes of acute renal infarction.
Page:90—95
11. The successful clinical outcomes of pregnant women with advanced chronic kidney disease.
Page:84—89
12. Changes in urinary potassium excretion in patients with chronic kidney disease.
Page:78—83
13. Adenosine monophosphate-activated protein kinase in diabetic nephropathy.
Page:69—77
14. Genetic diagnosis of autosomal dominant polycystic kidney disease: linkage analysis versus direct mutation analysis.
Page:67—68
15. Technique failure in Korean incident peritoneal dialysis patients: a national population-based study.
Page:245—251
16. Pulmonary vein isolation alone and combined with renal sympathetic denervation in chronic kidney disease patients with refractory atrial fibrillation.
Page:237—244
17. Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy.
Page:233—236
18. Comparison of clinical characteristics of patients with acute kidney injury after intravenous versus inhaled colistin therapy.
Page:229—232
19. Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure.
Page:219—228
20. The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy.
Page:212—218
21. Current characteristics of dialysis therapy in Korea: 2015 registry data focusing on elderly patients.
Page:204—211
22. Diagnosis and treatment of patients with IgA nephropathy in Japan.
Page:197—203
23. Interleukin-6 signaling in podocyte hypertrophy.
Page:195—196
24. Bullous skin lesions in a patient with end-stage renal disease combined with myeloma and primary amyloidosis.
Page:263—264
25. Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma.
Page:259—262
26. Unmasked chronic renal function deterioration after unilateral adrenalectomy in patients with primary aldosteronism.
Page:255—258
27. Acute interstitial nephritis induced by Solanum nigrum.
Page:252—254
28. Bilateral ureteral calcification with left kidney hydronephrosis in systemic lupus erythematosus.
Page:65—66
29. Pulmonary hypertension in chronic kidney disease: what could change the fate?.
Page:63—64
30. An unusual case of fistula formation and thrombosis between arteriovenous graft and a native vein.
Page:59—62
31. Warfarin skin necrosis mimicking calciphylaxis in a patient with secondary hyperparathyroidism undergoing peritoneal dialysis.
Page:55—58
32. Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation.
Page:50—54
33. Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients.
Page:42—49
34. Clinical utility of far-infrared therapy for improvement of vascular access blood flow and pain control in hemodialysis patients.
Page:35—41
35. Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility.
Page:29—34
36. Serum 25-hydroxyvitamin D as a predictor of hospitalization-free survival in predialysis and dialysis patients with chronic kidney disease: a single-center prospective observational analysis.
Page:22—28
37. Direct vascular actions of quercetin in aorta from renal hypertensive rats.
Page:15—21
38. Metabolic syndrome and obesity in peritoneal dialysis.
Page:10—14
39. Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?.
Page:3—9
40. Is Klotho deficiency independently associated with cardiovascular risk in chronic kidney disease?.
Page:1—2
41. The authors reply.
Page:193—193
42. The association between acute kidney injury in renal infarction and progression to chronic kidney disease.
Page:192—192
43. Henoch–Schönlein purpura nephritis and colitis in an adult patient with alcoholic liver cirrhosis.
Page:190—191
44. Cardiac arrest caused by nafamostat mesilate.
Page:187—189
45. Rhabdomyolysis in a patient taking nebivolol.
Page:182—186
46. High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients.
Page:176—181
47. Low prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis.
Page:169—175
48. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India.
Page:165—168
49. Predictive factors of acute kidney injury in patients undergoing rectal surgery.
Page:160—164
50. Plasma endocan level and prognosis of immunoglobulin A nephropathy.
Page:152—159
51. Elevated serum immunoglobulin E level as a marker for progression of immunoglobulin A nephropathy.
Page:147—151
52. Cicletanine-induced hyponatremia and hypokalemia in kidney transplant patients.
Page:142—146
53. Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis.
Page:133—141
54. Open the black box; is urine valuable for screening BK virus-associated nephropathy?.
Page:131—132